NCT05881811View on ClinicalTrials.gov

The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

April 24, 2023

Study Completion Date

June 5, 2023

Conditions
PHN - Post-Herpetic Neuritis
Interventions
DRUG

HSK16149，probenecid, cimetidine

40mg HSK16149 single dose, fasted; 500mg probenecid QID from D1\~D4 200mg cimetidine QID from D1\~D4

Trial Locations (1)

Unknown

Beijing Jishuitan Hoispital, Beijing

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY